Product image of Glimepiride Zentiva (Glimepiride) supplied by GNH India

Glimepiride Zentiva

Active Ingredient:
Glimepiride
Origin:
EU

Glimepiride Zentiva (Glimepiride)

Glimepiride Zentiva is a prescription oral medication that contains the active ingredient glimepiride, a second‑generation sulfonylurea used for managing blood glucose. It is marketed in the European Union and is supplied in tablet form, although specific strength and dosage form details are not disclosed here. The product belongs to the antidiabetic, oral hypoglycemic therapeutic class.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepiride Zentiva is indicated for the treatment of type 2 diabetes mellitus as part of a comprehensive diabetes management plan. It may be used in combination with diet, exercise, and other antidiabetic agents when needed.

  • Improves glycemic control in adults with type 2 diabetes.
  • Used as monotherapy when metformin is contraindicated.
  • Can be combined with metformin or other oral agents.
  • May be added to insulin therapy for additional glucose lowering.
  • Supports long‑term management of hyperglycemia alongside lifestyle measures.

Side Effects

Glimepiride Zentiva may cause a range of side effects, some of which are more frequent than others. Patients should be aware of both common and serious reactions.

Common

  • Mild hypoglycemia, especially with missed meals.
  • Nausea or abdominal discomfort.
  • Headache or dizziness.
  • Weight gain due to increased insulin activity.

Serious

  • Severe hypoglycemia requiring assistance.
  • Allergic reactions such as rash or angioedema.
  • Hepatic dysfunction indicated by jaundice or elevated liver enzymes.

Precautions & Warnings

Before starting Glimepiride Zentiva, several precautionary measures should be considered to ensure safe use.

  • Assess renal and hepatic function prior to initiation.
  • Monitor blood glucose regularly to detect hypoglycemia.
  • Use cautiously in elderly patients who may be more susceptible to low blood sugar.
  • Avoid use during pregnancy or breastfeeding unless clearly indicated.
  • Review all concomitant medications for potential interactions.
  • Educate patients on recognizing and managing hypoglycemic episodes.

Avoid Interactions

Glimepiride Zentiva can interact with various drugs, affecting its efficacy or safety profile. Understanding these interactions helps optimize therapy.

Avoid

  • Other sulfonylureas or insulin secretagogues that may increase hypoglycemia risk.
  • Strong CYP2C9 inhibitors (e.g., fluconazole) that raise glimepiride levels.
  • High‑dose aspirin or NSAIDs that may potentiate hypoglycemia.

Use with caution

  • Beta‑blockers, which can mask hypoglycemia symptoms.
  • Thiazide diuretics, which may affect glucose control.
  • Antifungal agents like ketoconazole that modestly increase drug exposure.

Frequently Asked Questions

Glimepiride binds to the sulfonylurea receptor (SUR1) on pancreatic beta‑cells, closing ATP‑sensitive potassium channels, which leads to cell depolarization and increased insulin secretion.

Yes, it can be prescribed as monotherapy when other first‑line agents such as metformin are unsuitable or not tolerated.

It is generally taken once daily with breakfast or the first main meal to reduce the risk of hypoglycemia, but exact timing should follow the prescribing physician’s advice.

Common signs include sweating, shakiness, rapid heartbeat, hunger, confusion, and dizziness. Severe hypoglycemia may cause loss of consciousness or seizures.

Dose reduction or careful monitoring is recommended for patients with moderate to severe renal impairment, as reduced clearance can increase the risk of hypoglycemia.

Glimepiride is generally not recommended during pregnancy; alternative insulin therapy is preferred unless the benefits outweigh the risks.

Take the missed dose as soon as you remember, unless it is close to the time of the next scheduled dose. Do not double the dose; consult your healthcare provider for guidance.

Maintain a consistent carbohydrate intake and follow a balanced diet as advised by a dietitian to help stabilize blood glucose levels.

Frequent self‑monitoring is advised, especially when initiating therapy or adjusting the dose, to detect hypoglycemia or inadequate control.

Other sulfonylureas, insulin, beta‑blockers, and certain antibiotics or antifungals can potentiate hypoglycemia and should be reviewed by a clinician.

Weight gain is a possible side effect due to increased insulin levels; lifestyle measures and regular monitoring can help manage this effect.

No, Glimepiride Zentiva is a prescription‑only medication and must be prescribed by a qualified healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT